Triple

T12448472
Position Surface form Disambiguated ID Type / Status
Subject Gruber Genetics Prize E297463 entity
Predicate notableRecipient P108 FINISHED
Object Rudolf Jaenisch
Rudolf Jaenisch is a pioneering molecular biologist known for his groundbreaking work in transgenic animals, epigenetics, and stem cell research.
E984025 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rudolf Jaenisch | Statement: [Gruber Genetics Prize, notableRecipient, Rudolf Jaenisch]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Rudolf Jaenisch
Context triple: [Gruber Genetics Prize, notableRecipient, Rudolf Jaenisch]
  • A. Mario Capecchi
    Mario Capecchi is an Italian-born American molecular geneticist and Nobel laureate renowned for developing gene targeting in mouse embryonic stem cells, a breakthrough that revolutionized the study of gene function in mammals.
  • B. Sir Martin Evans
    Sir Martin Evans is a British biologist and Nobel Prize–winning pioneer of embryonic stem cell research whose work enabled the development of genetically modified mice for studying human disease.
  • C. John B. Gurdon
    John B. Gurdon is a British developmental biologist renowned for his pioneering work in nuclear reprogramming and cloning, which demonstrated that mature cells can be reverted to an embryonic state.
  • D. Stanley N. Cohen
    Stanley N. Cohen is an American geneticist and a pioneer of recombinant DNA technology, best known for co-developing methods to clone and manipulate DNA in bacteria.
  • E. J. Michael Bishop
    J. Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine for discovering the cellular origin of retroviral oncogenes, fundamentally advancing cancer biology.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Rudolf Jaenisch
Triple: [Gruber Genetics Prize, notableRecipient, Rudolf Jaenisch]
Generated description
Rudolf Jaenisch is a pioneering molecular biologist known for his groundbreaking work in transgenic animals, epigenetics, and stem cell research.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Rudolf Jaenisch
Target entity description: Rudolf Jaenisch is a pioneering molecular biologist known for his groundbreaking work in transgenic animals, epigenetics, and stem cell research.
  • A. Mario Capecchi
    Mario Capecchi is an Italian-born American molecular geneticist and Nobel laureate renowned for developing gene targeting in mouse embryonic stem cells, a breakthrough that revolutionized the study of gene function in mammals.
  • B. Sir Martin Evans
    Sir Martin Evans is a British biologist and Nobel Prize–winning pioneer of embryonic stem cell research whose work enabled the development of genetically modified mice for studying human disease.
  • C. John B. Gurdon
    John B. Gurdon is a British developmental biologist renowned for his pioneering work in nuclear reprogramming and cloning, which demonstrated that mature cells can be reverted to an embryonic state.
  • D. Stanley N. Cohen
    Stanley N. Cohen is an American geneticist and a pioneer of recombinant DNA technology, best known for co-developing methods to clone and manipulate DNA in bacteria.
  • E. J. Michael Bishop
    J. Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine for discovering the cellular origin of retroviral oncogenes, fundamentally advancing cancer biology.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6ada166c48190b902972cd2408fa3 completed April 8, 2026, 7:33 p.m.
NER Named-entity recognition batch_69d94d9e592c81908cf7f3ca170d942c completed April 10, 2026, 7:21 p.m.
NED1 Entity disambiguation (via context triple) batch_69f63f1501448190b0a95d7cd249ca9d completed May 2, 2026, 6:14 p.m.
NEDg Description generation batch_69f640ef7dd08190bf78d04cffac1a44 completed May 2, 2026, 6:22 p.m.
NED2 Entity disambiguation (via description) batch_69f641abe114819093d99a327f2220c2 completed May 2, 2026, 6:25 p.m.
Created at: April 8, 2026, 9:56 p.m.